Developmental biologists discover how a critical protein shapes gallbladder formation
The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...
Frontiers12d
Novel Therapeutic Approaches for Biliary Tract Cancer and Hepatocellular Carcinoma, Volume II
Hepatobiliary cancers, which include biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), are among the most lethal ...
Medscape5d
The Intestinal Absorption of Biliary and Dietary Cholesterol as a Drug Target for Lowering the Plasma Cholesterol Level
Prev Cardiol. 2003;6(1) © 2003 Le Jacq Communications, Inc. Cite this: The Intestinal Absorption of Biliary and Dietary Cholesterol as a Drug Target for Lowering the ...
Biliary Atresia Market Expected to rise, 2034 | Mirium Pharmaceuticals, Albireo, Intercept Pharmaceuticals, expected to drive market
The Biliary Atresia market growth is driven by factors like increase in the prevalence of Biliary Atresia, investments in ...
pharmaphorum4d
Imfinzi faces Keytruda competition in biliary tract cancer
Biliary tract cancer occurs in the bile ducts ... had more good news with the drug today from a clinical trial in renal cell carcinoma, a form of kidney cancer. In the KEYNOTE-564 study, Keytruda ...
ascopubs.org19d
Expression of Trop2, Nectin-4, and FOLR1 cell surface markers in biliary tract cancers: Is it time to repurpose drugs?
Radiomics-based prediction of HCC response to atezolizumab/bevacizumab. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...
ascopubs.org19d
Clinical landscape of cell free DNA alterations in patients with advanced biliary tract cancer treated with targeted therapies.
Analysis of clinically actionable alterations in baseline tumor versus plasma samples in participants of the TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer ...